Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mucor racemosus refers to preparations derived from the fungal species of the same name, primarily utilized in clinical medicine as a diagnostic allergen extract. It is a standard component of fungal allergen panels used in skin prick testing (SPT) and serum-specific IgE assays to identify sensitization in patients with respiratory conditions such as bronchial asthma and allergic rhinitis. Beyond its diagnostic role, purified extracts of *Mucor racemosus* (often termed *Mucor racemosus e voluminae cellulae*) are employed in research to investigate innate immune responses and calcium signaling in human epithelial cells. Studies have demonstrated that these extracts can modulate intracellular calcium concentrations by interacting with transient receptor potential (TRP) channels, specifically TRPV1 and TRPM8. Historically, *Mucor racemosus* has also been associated with isopathic or homeopathic preparations intended for the treatment of circulatory and inflammatory disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mucor racemosus.